DRMA stock analysis: momentum, squeeze and dilution
MonScreener's historical stock analysis for DRMA, using the latest stored scan snapshot. Review the recorded momentum score, float and volume data, short-pressure fields and SEC dilution context that were available on that date.
- Snapshot price
- $1.38
- Snapshot session change
- +27.78%
- Sector
- Health Care
- Market capitalization
- 5.55M
- Session volume
- 16,783,393
- Relative volume
- 26.04×
- Float
- 3.17M
- MonScreener score
- 70/100 · grade B
- Risk band
- High
- Short float
- 1.26%
- Cost to borrow
- 40.62%
- Days to cover
- 0.08
- Dilution risk
- HIGH
- Registered offering capacity vs. float value
- 2287.20%
- SEC filing warning
- Present
- Snapshot date
- 2026-08-13
- Data source
- historical snapshot
Historical scan snapshot timestamp: 2026-08-13. Snapshot values can be stale or incomplete; the interactive stock analysis loads separately.
Momentum score and grade
The stored snapshot scored DRMA at 70/100 with a B grade. The score combines available momentum, float, volume, catalyst, squeeze and dilution inputs. It is a research ranking, not a recommendation or forecast.
Short-squeeze and borrow context
Available fields in this snapshot include short float 1.26%, cost to borrow 40.62%, 0.08 days to cover. These values can change quickly and may come from delayed or limited provider coverage. Compare them with float, liquidity, a verifiable catalyst and current broker data. Learn how MonScreener evaluates squeeze candidates.
SEC dilution context
The stored snapshot included an SEC filing warning. Registered offering capacity was estimated at 2287.20% of float market value. Automated filing signals can miss or misread terms, so confirm the latest primary filing before acting. Read the SEC dilution research guide.
Explore: Stock Screener · Prediction Track Record · MonScreener home